immunoglobulin G4-related sclerosing disease
Also known as IgG4-RD, IgG4-related disease, IgG4-related sclerosing disease, IgG4-related systemic disease+10 more
IgG4-RD, IgG4-related disease, IgG4-related sclerosing disease, IgG4-related systemic disease, IgG4-associated disease, IgG4-positive multiorgan lymphoproliferative syndrome, IgG4-related autoimmune disease, IgG4-related systemic sclerosing disease, IgG4-syndrome, hyper-IgG4 disease, multifocal fibrosclerosis, multifocal idiopathic fibrosclerosis, systemic IgG4-related plasmacytic syndrome, systemic IgG4-related sclerosing syndrome.
Recent clinical, regulatory, research and industry developments relating to this disease.
A Phase IIa, Single-Site, Open-Label Study of Efgartigimod in Patients With IgG4-Related Disease
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
IgG4-RD, IgG4-related disease, IgG4-related sclerosing disease, IgG4-related systemic disease, IgG4-associated disease, IgG4-positive multiorgan lymphoproliferative syndrome, IgG4-related autoimmune disease, IgG4-related systemic sclerosing disease, IgG4-syndrome, hyper-IgG4 disease, multifocal fibrosclerosis, multifocal idiopathic fibrosclerosis, systemic IgG4-related plasmacytic syndrome, systemic IgG4-related sclerosing syndrome
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Related entities are derived from literature co-mention (studied together) — associative, not causal.